ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,381.74
      0.21%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Jasper Therapeutics Inc (JSPRW) Quote

      Jasper Therapeutics Inc

      Jasper Therapeutics Inc (JSPRW)

      NASDAQ
      0.204599
      -0.0154
      (-7.00%)
      Closed June 23 4:00PM
      Delayed by 15 minutes
      0.1974
      -0.0072
      (-3.52%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.204599
      Bid
      0.1311
      Ask
      0.25
      Volume
      18,940
      0.145 Day's Range 0.2075
      0.0351 52 Week Range 0.3818
      Market Cap
      334.145M
      Previous Close
      0.22
      Open
      0.2075
      Last Trade
      43
      @
      0.1974
      Last Trade Time
      Financial Volume
      $ 3,343
      VWAP
      0.176519
      Average Volume (3m)
      17,204
      Shares Outstanding
      15,085,553
      Dividend Yield
      -
      PE Ratio
      -5.18
      Earnings Per Share (EPS)
      -4.27
      Revenue
      -
      Net Profit
      -64.47M

      About Jasper Therapeutics Inc

      Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.jaspertherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPRW. The last closing price for Jasper Therapeutics was $0.22. Over the last year, Jasper Therapeutics shares have traded in a share price range of $ 0.0351 to $ 0.3818.

      Jasper Therapeutics currently has 15,085,553 shares outstanding. The market capitalization of Jasper Therapeutics is $334.14 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -5.18.

      JSPRW Latest News

      More News

      Form 8-K - Current report

      June 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 12 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      June 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 12 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 10 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      June 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.001101-0.535245503160.20570.220.14588500.2189837CS
      40.0148997.853979968370.18970.220.14541840.21181192CS
      12-0.019701-8.783325902810.22430.23230.101172040.1697332CS
      260.124599155.748750.080.38180.0351238330.15825198CS
      520.07459957.38384615380.130.38180.0351194230.12873968CS
      156-1.525401-88.17346820811.732.240.016285950.52046181CS
      260-1.525401-88.17346820811.732.240.016285950.52046181CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SHCRSharecare Inc
      $ 1.365
      (76.27%)
      		56.33M
      NXLNexalin Technologies Inc
      $ 1.7499
      (59.08%)
      		57.58M
      FUFUBitFuFu Inc
      $ 6.1209
      (56.95%)
      		2.5M
      SPECSpectaire Holdings Inc
      $ 0.50
      (47.06%)
      		65.27M
      FLFVFeutune Light Acquisition Corporation
      $ 2.5502
      (-69.75%)
      		862.38k
      FLFVUFeutune Light Acquisition Corporation
      $ 2.75
      (-66.83%)
      		16.5k
      RWODRedwoods Acquisition Corporation
      $ 2.34
      (-60.34%)
      		155.96k
      KAVLKaival Brands Innovations Group Inc
      $ 1.23
      (-57.14%)
      		4.92M
      RWODURedwoods Acquisition Corporation
      $ 3.24
      (-56.28%)
      		1.47k
      NVDANVIDIA Corporation
      $ 126.57
      (-3.22%)
      		658.13M
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SIRISirius XM Holdings Inc
      $ 2.94
      (1.38%)
      		330.66M
      AAPLApple Inc
      $ 207.49
      (-1.04%)
      		246.38M
      NKLANikola Corporation
      $ 0.3466
      (5.16%)
      		193.36M

      Discussion

      View Full Feed
      capgain capgain 4 minutes ago
      Sign Of The Gypsy Queen

      https://www.youtube.com/watch?v=LUwviJMVV5g
      XenaLives XenaLives 6 minutes ago
      So private deep pockets will be able to swarm in and scoop it up....

      Got it......
      LetGoodTimesRoll LetGoodTimesRoll 6 minutes ago
      And YOU guy are a DEMENTED LIAR!
      FOXO
      LetGoodTimesRoll LetGoodTimesRoll 9 minutes ago
      Said the PATHOLOGICAL LIAR!
      RNVA
      kabunushi kabunushi 9 minutes ago
      I don't have any idea what caused you to flip out on me in the first place but your attitude is tiring. I have no desire to spend on any energy sustaining any personal feuds here if I can possibly help it. Is it possible to ask you to kindly do an attitude reset and we start over fresh? I got no bee
      NWBO
      XenaLives XenaLives 10 minutes ago
      Start reading here to understand how legitimate companies are being undermined by the current capitalist cabal:

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174589960
      capgain capgain 10 minutes ago
      Suite Madame Blue

      https://www.youtube.com/watch?v=CkkQPxoxJJY
      kabunushi kabunushi 14 minutes ago
      Thanks a lot for providing the source for that statement.

      The $200-300k or whatever price paid we believe is paid by Specials isn't coming into NW's accounts as income by any means. We get a much smaller amount. e.g. Specials income started in Q1/2023 at 880k but then dipped to 200k a
      ASM
      Tom turtles Tom turtles 14 minutes ago
      You guys are in Dreamland. Team up with Rennova ? Haha....This is toast !
      FOXO
      capgain capgain 15 minutes ago
      Changes

      https://www.youtube.com/watch?v=eh1dVptApmc
      SilkRoad SilkRoad 19 minutes ago
      The Dragon has already been released in The Year of The Dragon and it is called BAM-1 DragonSilk a/k/a Spydasilk. It is a little baby dragon, but it is growing exponentially. The Dragon is the Kraken. As word spreads, it will be known.

      Kong on.
      KBLB
      STILL TOWING STILL TOWING 19 minutes ago
      Thanks MM. It sure would be nice to hear from the company..The lack of fund raising coupled with our not filing makes one think Ward has finally given up..In the interim. I'll grab a seat next to Livefree and wait some more..
      Have you seen anything mentioning the missing head of the Mexican
      MRGE
      maverick_1 maverick_1 22 minutes ago
      Bright Boy & Kabunushi

      For the record, I do know Kabunushi
      entire working history. He has never worked in a Biotech nor in the healthcare industry PERIOD.

      Kabunushi has worked for a Fortune 100 company for most of his life.

      I do have the DOCUMEN
      NWBO
      capgain capgain 24 minutes ago
      Great to see you B2B!!
      Ranb2khz Ranb2khz 26 minutes ago
      A Joyful Heart

      ~ No matter what is happening around us, we can rejoice in our Father's presence.

      Scripture Reading: www.biblegateway.com/passage/?search=Psalms+16%3A7-9&version=HCSB,KJV Psalms 16:7-9

      Are you happy?

      Your answer likely dep
      rikkie rikkie 28 minutes ago
      JLPTNG, you forgot to mention one more thing, NO DEBT!! 🤣
      LWLG
      real777mellon real777mellon 28 minutes ago
      Morgan Stanley upgrade to $27. Oil is in a longterm downward triangle break and they are reporting a goal of $100 a share in Bloomberg Linea - the CEO said $100 is his goal by 2031 - I believe he's undershooting because it's better to exceed expectations in stock growth :) And because he underestima
      YPF
      Tom turtles Tom turtles 28 minutes ago
      GREAT MANAGEMENT = .000001...What's bad management ? .000000000001 ? Go crawl back under a rock you mental patient. Why don't you go to Myrtle Beach Health centers...You Certainly need it.
      RNVA
      Preciouslife1 Preciouslife1 35 minutes ago
      https://www.cbssports.com/mlb/news/yankees-aaron-judge-says-hes-skipping-2024-home-run-derby-theres-no-need-this-year/
      PC retired PC retired 39 minutes ago
      I am puzzled at the anger displayed by some of these Holcomb backers when the simple fact that the "tech" does not work is mentioned. It suggests to me that the truth hurts.
      ASRE
      NotSure2 NotSure2 50 minutes ago
      Here it is:

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174334943

      Lee might have miss spoke...
      But if not, where is the revenue...

      $200k - 300k x 200 patients in that short timeframe .... (2 months)
      NWBO

      Your Recent History

      NASDAQ
      JSPRW
      Jasper Therapeutics
      Delayed Upgrade Clock